Response Genetics, Inc. (RGDX) Reports Wider Q2 Loss of $0.08/Share
Tweet
Share
E-mailGet Alerts RGDX Hot Sheet
Price: $0.27 --0%
Financial Fact:
Research and development: 268.2K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Research and development: 268.2K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Response Genetics, Inc. (NASDAQ: RGDX) reported Q2 EPS of ($0.08), versus ($0.04) reported last year. Revenue for the quarter came in at $4.3 million, versus $3.9 million reported last year.
For earnings history and earnings-related data on Response Genetics, Inc. (RGDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Vireo Growth completes acquisition of C21 Investments
- Beike (BEKE) PT Raised to $23 at Morgan Stanley
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
